{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:50:23Z","timestamp":1792266623001,"version":"4.4.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001342","name":"South Africa Department of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189738","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:51:19Z","timestamp":1792079479000},"page":"189738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in the metabolic network and signalling pathways of cancer stem cells in therapy resistance"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-1047","authenticated-orcid":false,"given":"Onyisi C.","family":"Didamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8214-4563","authenticated-orcid":false,"given":"Sajan","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-827X","authenticated-orcid":false,"given":"Heidi","family":"Abrahamse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189738_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.36.s.1.6.x","article-title":"Stem cells in normal breast development and breast cancer","volume":"36","author":"Dontu","year":"2003","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s43556-026-00516-2","article-title":"Cancer stem cells and drug resistance in cancer: molecular mechanisms and therapeutic targets","volume":"7","author":"Hamdy","year":"2026","journal-title":"Mol. Biomed."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0015","first-page":"1063","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0020","article-title":"Cancer stem cells in focus: deciphering the dynamic functional landscape of stemness in cancer","volume":"1880","author":"Nwokolo","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-023-01877-w","article-title":"Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer","volume":"22","author":"Zeng","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.20517\/cdr.2022.20","article-title":"Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces","volume":"5","author":"Safa","year":"2022","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12935-023-03130-2","article-title":"Cancer stem cells and their niche in cancer progression and therapy","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189738_bb0045","doi-asserted-by":"crossref","first-page":"1424163","DOI":"10.3389\/freae.2024.1424163","article-title":"Interplay between epigenetics and metabolism controls cancer stem cell plasticity","volume":"2","author":"Choi","year":"2024","journal-title":"Front. Epigenet. Epigenom."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0050","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","article-title":"Next-generation combination approaches for immune checkpoint therapy","volume":"25","author":"Goswami","year":"2024","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189738_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.692940","article-title":"Cancer stem cells: emerging key players in immune evasion of cancers","volume":"9","author":"Lei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189738_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/cells14100717","article-title":"The metabolic landscape of cancer stem cells: insights and implications for therapy","volume":"14","author":"Milella","year":"2025","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189738_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232686","article-title":"Metabolic profiles of cancer stem cells and normal stem cells and their therapeutic significance","volume":"12","author":"Stouras","year":"2023","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189738_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233790","article-title":"Metabolism in cancer stem cells: targets for clinical treatment","volume":"11","author":"Wen","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0080","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic plasticity and cancer stem cell metabolism: exploring the glycolysis-OXPHOS switch as a mechanism for resistance and tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/cancers15010062","article-title":"The effect of oxidative phosphorylation on cancer drug resistance","volume":"15","author":"Zhao","year":"2023","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189738_bb0090","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.188292.112","article-title":"Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells","volume":"26","author":"Janiszewska","year":"2012","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","article-title":"Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance","volume":"18","author":"Shang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110623","article-title":"Hypoxia-mediated cancer stem cell resistance and targeted therapy","volume":"130","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/onc.2017.368","article-title":"Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia","volume":"37","author":"Peng","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0115","article-title":"PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1\u03b1","volume":"11","author":"Wei","year":"2024","journal-title":"Genes Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0120","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189738_bb0125","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.3390\/ijms262411769","article-title":"Putative role of fatty acid metabolic therapy using ketogenic diet and HIF-1\u03b1 inhibition in hepatocellular carcinoma: evidence from an in vitro study","volume":"26","author":"Kimura","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0130","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/jat.4365","article-title":"Inhibition of hypoxia-induced HIF-1\u03b1-mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells","volume":"42","author":"Yao","year":"2022","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102047","article-title":"Ubiquitination and receptor-mediated mitophagy converge to eliminate oxidation-damaged mitochondria during hypoxia","volume":"45","author":"Sulkshane","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0140","article-title":"Bisphenol a promotes the progression of colon cancer through dual-targeting of NADPH oxidase and mitochondrial electron-transport chain to produce ROS and activating HIF-1\u03b1\/VEGF\/PI3K\/AKT axis","volume":"13 - 2022","author":"Xia","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1431968","article-title":"Targeting cellular mitophagy as a strategy for human cancers","volume":"12","author":"Dong","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.756888","article-title":"Cancer stem cells: metabolic characterization for targeted cancer therapy","volume":"11","author":"Kaur","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0155","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s13402-025-01081-6","article-title":"Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches","volume":"48","author":"Lee","year":"2025","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0160","article-title":"Lipid metabolism dynamics in cancer stem cells: potential targets for cancers","volume":"15 - 2024","author":"Du","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s12967-024-05598-6","article-title":"Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells","volume":"22","author":"Mascaraque","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189738_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","article-title":"A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation","volume":"9","author":"Williams","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells14070517","article-title":"Core molecular clock factors regulate osteosarcoma stem cell survival and behavior via CSC\/EMT pathways and lipid droplet biogenesis","volume":"14","author":"Bhoumik","year":"2025","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189738_bb0180","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/1873-3468.14820","article-title":"Lipid droplets provide metabolic flexibility for cancer progression","volume":"598","author":"Safi","year":"2024","journal-title":"FEBS Lett."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189738_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011185","article-title":"Targeting lipid metabolism in cancer stem cells for anticancer treatment","volume":"25","author":"Singh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147717","article-title":"Inhibition of fatty acid synthase decreases expression of stemness markers in glioma stem cells","volume":"11","author":"Yasumoto","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.3101","article-title":"Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells","volume":"38","author":"Visweswaran","year":"2019","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10495-012-0776-4","article-title":"Fatty acid synthase inhibitor cerulenin inhibits topoisomerase I catalytic activity and augments SN-38-induced apoptosis","volume":"18","author":"Jeong","year":"2013","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100660","article-title":"Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN\/APP axis as novel therapeutic strategies","volume":"65","author":"Chen","year":"2024","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-010-1300-6","article-title":"Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase","volume":"130","author":"Pandey","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0215","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41374-021-00724-0","article-title":"Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells","volume":"102","author":"Luo","year":"2022","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0220","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s42003-025-07720-w","article-title":"CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells","volume":"8","author":"Zhu","year":"2025","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0225","doi-asserted-by":"crossref","first-page":"12869","DOI":"10.18632\/oncotarget.7331","article-title":"SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189738_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111903","article-title":"Cancer stem cells amino acid metabolism: roles, mechanisms, and intervention strategies","author":"Gong","year":"2025","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0235","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/antiox14121413","article-title":"Redox\u2013amino acid metabolic crosstalk in ovarian cancer stem cells: integrating metabolic reprogramming, signaling, and the tumor microenvironment","volume":"14","author":"Liu","year":"2025","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0240","article-title":"Glutamine metabolism: molecular regulation, biological functions, and diseases","volume":"6","author":"Kumar","year":"2025","journal-title":"MedComm (2020)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0245","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3390\/ijms24032337","article-title":"Glutamine metabolism in cancer stem cells: a complex liaison in the tumor microenvironment","volume":"24","author":"Pacifico","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189738_bb0250","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.7150\/thno.58655","article-title":"GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy","volume":"11","author":"Mukha","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0255","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0260","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41598-017-18762-4","article-title":"Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0265","article-title":"Unraveling the role of mitochondrial dynamics in cancer stem cells: molecular basis and therapeutic implications","volume":"1880","author":"Giannitti","year":"2025","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2026.189738_bb0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2021.09.024","article-title":"The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer","volume":"176","author":"Fontana","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11033-025-10748-0","article-title":"Cancer stem cells: mitochondria signalling pathway and strategies for therapeutic interventions","volume":"52","author":"Tan","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0280","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stem.2021.02.011","article-title":"Mitochondria as signaling organelles control mammalian stem cell fate","volume":"28","author":"Chakrabarty","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0285","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","article-title":"Mitochondria in cancer stem cells: Achilles heel or hard armor","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0290","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/2211-5463.13207","article-title":"The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagy","volume":"11","author":"Liu","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189738_bb0295","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.18632\/oncotarget.24285","article-title":"Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling","volume":"9","author":"Peiris-Pag\u00e8s","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189738_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107574","article-title":"Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells","volume":"150","author":"Sami Alkafaas","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12964-023-01160-x","article-title":"Cancer stem cell fate determination: mito-nuclear communication","volume":"21","author":"Fan","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0310","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1007\/s00018-021-03773-2","article-title":"Mitochondrial dynamics in cancer stem cells","volume":"78","author":"Sessions","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0315","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/1878-0261.13578","article-title":"Mitochondrial fusion\u2013fission dynamics and its involvement in colorectal cancer","volume":"18","author":"Wu","year":"2024","journal-title":"Mol. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0320","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41416-024-02670-2","article-title":"DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma","volume":"130","author":"Wang","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41556-024-01574-w","article-title":"Metabolic rewiring in skin epidermis drives tolerance to oncogenic mutations","volume":"27","author":"Hemalatha","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0330","doi-asserted-by":"crossref","first-page":"2202956","DOI":"10.1002\/advs.202202956","article-title":"Tumor cell-intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid \u03b2-oxidation","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189738_bb0335","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41589-024-01612-6","article-title":"Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling","volume":"20","author":"Li","year":"2024","journal-title":"Nat. Chem. Biol."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189738_bb0340","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1111\/bph.15401","article-title":"Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: novel mechanism for anti-cancer stem cell-targeted cancer therapy","volume":"179","author":"Praharaj","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0345","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1186\/s12967-025-07078-x","article-title":"The molecular mechanisms of mitochondrial dynamics and mitophagy and their complex association with cancer drug resistance","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"33","key":"10.1016\/j.bbcan.2026.189738_bb0350","doi-asserted-by":"crossref","first-page":"E4600","DOI":"10.1073\/pnas.1513433112","article-title":"Chemotherapy triggers HIF-1\u2013dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype","volume":"112","author":"Lu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0355","article-title":"Redox regulation of cancer stem cells: biology and therapeutic implications","volume":"3","author":"Du","year":"2024","journal-title":"MedComm Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semradonc.2018.10.003","article-title":"Targeting cancer stem cell redox metabolism to enhance therapy responses","volume":"29","author":"Luo","year":"2019","journal-title":"Semin. Radiat. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189738_bb0365","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/cancers12102780","article-title":"The metabolic heterogeneity and flexibility of cancer stem cells","volume":"12","author":"Tanabe","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189738_bb0370","series-title":"Seminars in Radiation Oncology","first-page":"42","article-title":"Targeting cancer stem cell redox metabolism to enhance therapy responses","author":"Luo","year":"2019"},{"key":"10.1016\/j.bbcan.2026.189738_bb0375","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.freeradbiomed.2021.04.006","article-title":"Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair","volume":"169","author":"Qin","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189738_bb0380","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41388-024-03054-9","article-title":"A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance","volume":"43","author":"Das","year":"2024","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0385","first-page":"215","article-title":"The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas","volume":"22","author":"Reiter-Brennan","year":"2018","journal-title":"Contemp. Oncol. (Pozn.)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41419-021-03543-9","article-title":"Rewiring of purine metabolism in response to acidosis stress in glioma stem cells","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0395","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s12276-026-01746-8","article-title":"The metabolic plasticity of cancer stem cells: bidirectional crosstalk with organ-resident cells","volume":"58","author":"Jang","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189738_bb0400","article-title":"Metabolic rewiring of the tumor microenvironment: therapeutic intervention of multi-pathway adaptations to impede cancer metastasis","volume":"13 - 2026","author":"Kaushik","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2026.189738_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.988295","article-title":"Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0410","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189738_bb0420","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.canlet.2020.08.044","article-title":"Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids","volume":"493","author":"Zhao","year":"2020","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0425","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0430","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2390","article-title":"Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion","volume":"84","author":"Yan","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0435","first-page":"147","article-title":"Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism","volume":"5","author":"Zhao","year":"2024","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167164","article-title":"Metabolic adaptations in cancer stem cells: a key to therapy resistance","volume":"1870","author":"Masoudi","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189738_bb0445","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.3390\/ijms21239125","article-title":"Cancer stem cell-associated pathways in the metabolic reprogramming of breast cancer","volume":"21","author":"El-Sahli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189738_bb0450","article-title":"Notch signaling in cancer: metabolic reprogramming and therapeutic implications","volume":"16 - 2025","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"39","key":"10.1016\/j.bbcan.2026.189738_bb0455","doi-asserted-by":"crossref","first-page":"64932","DOI":"10.18632\/oncotarget.18117","article-title":"Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells","volume":"8","author":"Bayin","year":"2017","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189738_bb0460","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.3390\/cancers14215468","article-title":"Wnt\/\u03b2-catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma","volume":"14","author":"Leung","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189738_bb0465","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/cancers11070904","article-title":"Wnt signaling in cancer metabolism and immunity","volume":"11","author":"El-Sahli","year":"2019","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189738_bb0470","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.15252\/embj.201488598","article-title":"Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer","volume":"33","author":"Pate","year":"2014","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0475","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","article-title":"Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/\u03b2-catenin\/c-Myc signaling and reprogramming glycolysis","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-017-0623-x","article-title":"Regulation of stem-like cancer cells by glutamine through \u03b2-catenin pathway mediated by redox signaling","volume":"16","author":"Liao","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189738_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2026.05.002","article-title":"Hippo signalling in cellular and tissue-level metabolism across health and disease","author":"Bigot","year":"2026","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0490","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189738_bb0495","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.omtn.2021.07.004","article-title":"LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway","volume":"26","author":"Xu","year":"2021","journal-title":"Mol. Ther. Nucleic acids"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189738_bb0500","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.7150\/thno.32915","article-title":"Metastatic colorectal cancer rewrites metabolic program through a Glut3-YAP-dependent signaling circuit","volume":"9","author":"Kuo","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0505","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cancers12010124","article-title":"Energy metabolism in cancer: the roles of STAT3 and STAT5 in the regulation of metabolism-related genes","volume":"12","author":"Valle-Mendiola","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0510","article-title":"The JAK\/STAT pathway in cancer: from molecular mechanisms to clinical applications","volume":"5","author":"Liao","year":"2026","journal-title":"MedComm Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0515","doi-asserted-by":"crossref","first-page":"823","DOI":"10.18632\/aging.100232","article-title":"A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction","volume":"2","author":"Demaria","year":"2010","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0520","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189738_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00500","article-title":"The influence of metabolism on drug response in cancer","volume":"8","author":"Zaal","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101368","article-title":"Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects","volume":"103","author":"Zhang","year":"2025","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0535","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41420-025-02670-y","article-title":"Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions","volume":"11","author":"Qiu","year":"2025","journal-title":"Cell Death Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0540","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/stem.1662","article-title":"Targeting unique metabolic properties of breast tumor initiating cells","volume":"32","author":"Feng","year":"2014","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0545","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yexcr.2014.08.028","article-title":"Ovarian tumor-initiating cells display a flexible metabolism","volume":"328","author":"Anderson","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0550","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-022-03447-y","article-title":"Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer","volume":"20","author":"Sriramkumar","year":"2022","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189738_bb0555","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71244","article-title":"Metabolic reprogramming of cancer cells and therapeutics targeting cancer metabolism","volume":"14","author":"Punnasseril","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0560","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/cells11010140","article-title":"Amino acid metabolism in cancer drug resistance","volume":"11","author":"Yoo","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189738_bb0565","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1541-7786.MCR-17-0061","article-title":"PPAR\u03b4 reprograms glutamine metabolism in sorafenib-resistant HCC","volume":"15","author":"Kim","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189738_bb0570","series-title":"Exploiting ROS and Metabolic Differences to Kill Cisplatin Resistant Lung Cancer Oncotarget","author":"Wangpaichitr","year":"2017"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0575","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","article-title":"A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells","volume":"31","author":"Yoo","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189738_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118715","article-title":"Fuelling resistance: lipid metabolic rewiring in cancer response to chemotherapy and radiotherapy","volume":"193","author":"Piatrikova","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0585","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10555-024-10170-1","article-title":"Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?","volume":"43","author":"Vishwa","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0590","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/21655979.2019.1676485","article-title":"Targeting SREBP1 chemosensitizes colorectal cancer cells to gemcitabine by caspase-7 upregulation","volume":"10","author":"Shen","year":"2019","journal-title":"Bioengineered"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0595","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00432-024-05607-7","article-title":"Role of hydroxymethylglutharyl-coenzyme a reductase in the induction of stem-like states in breast cancer","volume":"150","author":"Marks","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115804","article-title":"Cell death and cancer: metabolic interconnections","volume":"44","author":"Dalseno","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189738_bb0605","series-title":"AMP-Activated Protein Kinase","first-page":"45","article-title":"AMPK regulation of cell growth, apoptosis, autophagy, and bioenergetics","author":"Villanueva-Paz","year":"2016"},{"key":"10.1016\/j.bbcan.2026.189738_bb0610","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2023.06.002","article-title":"mTOR in programmed cell death and its therapeutic implications","volume":"71","author":"Xie","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0615","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12943-025-02392-w","article-title":"Metabolic reprogramming promotes apoptosis resistance in acute lymphoblastic leukemia through CASP3 lactylation","volume":"24","author":"Lin","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0620","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/MNM.0000000000001587","article-title":"CD133 increases oxidative glucose metabolism of HT29 cancer cells by mitochondrial uncoupling and its inhibition enhances reactive oxygen species-inducing therapy","volume":"43","author":"Lee","year":"2022","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.bbcan.2026.189738_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.633305","article-title":"Cell metabolism and DNA repair pathways: implications for cancer therapy","volume":"9","author":"Sobanski","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189738_bb0630","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","article-title":"L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation","volume":"13","author":"Wagner","year":"2015","journal-title":"Cell Commun. Signal"},{"issue":"8021","key":"10.1016\/j.bbcan.2026.189738_bb0635","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0640","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1186\/s12967-025-07244-1","article-title":"Immunometabolic reprogramming in lung cancer: interplay between immune and stem-like cells in immune checkpoint inhibitor resistance","volume":"23","author":"Sung","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189738_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0650","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41419-023-06050-1","article-title":"Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189738_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/cells14141073","article-title":"Regulatory functions of microRNAs in cancer stem cells: mechanism, facts, and perspectives","volume":"14","author":"Mao","year":"2025","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189738_bb0660","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1136\/gutjnl-2020-320652","article-title":"RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0665","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/0008-5472.CAN-18-2505","article-title":"Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating mitochondrial transcription","volume":"79","author":"Fan","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189738_bb0670","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2018.10.025","article-title":"HIF-1\u03b1-induced miR-23a\u223c27a\u223c24 cluster promotes colorectal cancer progression via reprogramming metabolism","volume":"440-441","author":"Jin","year":"2019","journal-title":"Cancer Lett."},{"issue":"7239","key":"10.1016\/j.bbcan.2026.189738_bb0675","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"C-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0680","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13287-015-0153-7","article-title":"Gene expression signatures of breast cancer stem and progenitor cells do not exhibit features of Warburg metabolism","volume":"6","author":"Gordon","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0685","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/stem.2286","article-title":"Metabolic reprogramming and dependencies associated with epithelial cancer stem cells independent of the epithelial-mesenchymal transition program","volume":"34","author":"Aguilar","year":"2016","journal-title":"Stem Cells"},{"issue":"38","key":"10.1016\/j.bbcan.2026.189738_bb0690","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.1073\/pnas.1106704108","article-title":"Metabolic state of glioma stem cells and nontumorigenic cells","volume":"108","author":"Vlashi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189738_bb0695","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.18632\/oncotarget.2120","article-title":"Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine","volume":"5","author":"Isayev","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189738_bb0700","article-title":"Combinatorial strategies to target molecular and signaling pathways to disarm cancer stem cells","volume":"11","author":"Catara","year":"2021","journal-title":"Front. Oncol."},{"issue":"28","key":"10.1016\/j.bbcan.2026.189738_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202308539","article-title":"Manipulating redox homeostasis of cancer stem cells overcome chemotherapeutic resistance through photoactivatable biomimetic nanodiscs","volume":"20","author":"Wang","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0710","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-019-0500-6","article-title":"Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis","volume":"26","author":"Kogure","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0715","doi-asserted-by":"crossref","DOI":"10.1530\/REM-25-0003","article-title":"Targeting the bioenergetics of a resistant tumor: clinical insights into OXPHOS inhibition for cancer therapy","volume":"2025","author":"Akku\u015f","year":"2025","journal-title":"Redox Exp. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189738_bb0720","doi-asserted-by":"crossref","first-page":"2105126","DOI":"10.1002\/advs.202105126","article-title":"CRISPR\/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-fatty acid \u03b2-oxidation pathway","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0725","doi-asserted-by":"crossref","first-page":"e1336","DOI":"10.1038\/cddis.2014.285","article-title":"Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment","volume":"5","author":"Ciavardelli","year":"2014","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0730","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41598-019-39789-9","article-title":"2-Deoxy-D-glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype","volume":"9","author":"O'Neill","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0735","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.2892","article-title":"Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells","volume":"6","author":"Shibuya","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0740","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1172\/JCI121685","article-title":"Stress-induced epinephrine enhances lactate dehydrogenase a and promotes breast cancer stem-like cells","volume":"129","author":"Cui","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0745","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stemcr.2019.08.015","article-title":"ALDH-dependent glycolytic activation mediates stemness and paclitaxel resistance in patient-derived spheroid models of uterine endometrial cancer","volume":"13","author":"Mori","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0750","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189738_bb0755","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02242","article-title":"Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis","volume":"3","author":"Wheaton","year":"2014","journal-title":"elife"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189738_bb0760","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/neuonc\/nox243","article-title":"Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres","volume":"20","author":"Park","year":"2018","journal-title":"Neuro-oncology"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0765","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.18632\/oncotarget.14321","article-title":"Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma","volume":"8","author":"Petrachi","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0770","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.18632\/aging.100983","article-title":"Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)","volume":"8","author":"Fiorillo","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2026.189738_bb0775","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jprot.2016.10.002","article-title":"Proteomic analysis of pancreatic cancer stem cells: functional role of fatty acid synthesis and mevalonate pathways","volume":"150","author":"Brandi","year":"2017","journal-title":"J. Proteome"},{"issue":"7635","key":"10.1016\/j.bbcan.2026.189738_bb0780","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0785","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-016-3854-4","article-title":"Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention","volume":"158","author":"Colacino","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0790","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41419-018-0330-6","article-title":"Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer","volume":"9","author":"Wen","year":"2018","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.bbcan.2026.189738_bb0795","doi-asserted-by":"crossref","first-page":"31151","DOI":"10.18632\/oncotarget.5150","article-title":"Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0800","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41420-020-0258-3","article-title":"A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity","volume":"6","author":"Koch","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0805","doi-asserted-by":"crossref","first-page":"37028","DOI":"10.1038\/s41598-025-20528-2","article-title":"Glutaminase inhibitor CB-839 causes metabolic adjustments in colorectal cancer cells","volume":"15","author":"Spada","year":"2025","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189738_bb0810","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.3390\/ijms222010955","article-title":"L-type amino acid transporter 1 regulates cancer stemness and the expression of programmed cell death 1 ligand 1 in lung cancer cells","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0815","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10120-017-0720-y","article-title":"Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)","volume":"20","author":"Shitara","year":"2017","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189738_bb0820","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/cancers13040698","article-title":"Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential","volume":"13","author":"Courtois","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189738_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216847","article-title":"Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics","volume":"590","author":"Song","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40164-024-00586-4","article-title":"AOH1996 targets mitochondrial dynamics and metabolism in leukemic stem cells via mitochondrial PCNA inhibition","volume":"13","author":"Kang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0835","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","article-title":"AMPK\/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells","volume":"23","author":"Pei","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2026.189738_bb0840","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fonc.2019.00615","article-title":"Dodecyl-TPP targets mitochondria and potently eradicates cancer stem cells (CSCs): synergy with FDA-approved drugs and natural compounds (vitamin C and berberine)","volume":"9","author":"De Francesco","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0845","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7150\/thno.17647","article-title":"Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1","volume":"7","author":"Zhou","year":"2017","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0850","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1158\/0008-5472.CAN-15-2249","article-title":"Combined inhibition of DNMT and HDAC blocks the tumorigenicity of cancer stem-like cells and attenuates mammary tumor growth","volume":"76","author":"Pathania","year":"2016","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0855","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","article-title":"Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition","volume":"6","author":"Scott","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0860","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13020-025-01084-3","article-title":"FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1\/miR-34a-5p\/FoxM1 axis","volume":"20","author":"Cao","year":"2025","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0865","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00280-017-3381-y","article-title":"Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation","volume":"80","author":"Ouyang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189738_bb0870","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3892\/or.2015.3708","article-title":"Inhibitory action of pristimerin on hypoxia-mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells","volume":"33","author":"Zuo","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0875","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3892\/or.2016.4813","article-title":"Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1\u03b1 in vitro","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0880","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/neuros\/nyaa412","article-title":"A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent\/progressive glioblastoma","volume":"88","author":"Peereboom","year":"2021","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0885","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13287-020-01773-w","article-title":"Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189738_bb0890","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10637-018-0597-6","article-title":"A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours","volume":"36","author":"Aung","year":"2018","journal-title":"Investig. New Drugs"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054759","article-title":"ETC-159, an upstream Wnt inhibitor, induces tumour necrosis via modulation of angiogenesis in osteosarcoma","volume":"24","author":"Chua","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189738_bb0900","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3390\/cells14211710","article-title":"Cellular and molecular effects of targeting the CBP\/\u03b2-catenin interaction with PRI-724 in melanoma cells, drug-na\u00efve and resistant to inhibitors of BRAFV600 and MEK1\/2","volume":"14","author":"Gajos-Michniewicz","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189738_bb0905","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"7_Supplement","key":"10.1016\/j.bbcan.2026.189738_bb0910","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1538-7445.AM2023-4491","article-title":"TY-0584: a potent, orally available small molecule YAP\/TEAD inhibitor, exhibits anti-tumor effects in vitro and in vivo","volume":"83","author":"Liang","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0915","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189738_bb0920","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/cmdc.201700063","article-title":"Molecular features of the YAP inhibitor verteporfin: synthesis of hexasubstituted dipyrrins as potential inhibitors of YAP\/TAZ, the downstream effectors of the hippo pathway","volume":"12","author":"Gibault","year":"2017","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189738_bb0925","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/medicina60101715","article-title":"Napabucasin inhibits proliferation and migration of glioblastoma cells (U87) by regulating JAK2\/STAT3 signaling pathway","volume":"60","author":"\u00dcnl\u00fc","year":"2024","journal-title":"Medicina"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0930","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.apsb.2025.03.041","article-title":"Targeting the JAK2-STAT3-UCHL3-ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer","volume":"15","author":"Xin","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189738_bb0935","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189738_bb0940","doi-asserted-by":"crossref","first-page":"1486652","DOI":"10.3389\/fimmu.2024.1486652","article-title":"Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189738_bb0945","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41417-025-00947-z","article-title":"Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancer","volume":"32","author":"Lu","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189738_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004703","article-title":"Spatial transcriptomic-metabolic features of tumor foci and tumor capsule in microvascular invasion with hepatocellular carcinoma: a spatial multi-omics study","volume":"23","author":"Luo","year":"2026","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189738_bb0955","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21873\/cgp.20577","article-title":"Decoding the mechanisms of hepatocellular carcinoma cancer stem cells and identifying potential therapeutic strategies based on single-cell omics","volume":"23","author":"Tan","year":"2026","journal-title":"Cancer Genom. Proteom."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26002106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:30:28Z","timestamp":1792265428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26002106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":191,"alternative-id":["S0304419X26002106"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189738","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes in the metabolic network and signalling pathways of cancer stem cells in therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189738"}}